Literature DB >> 12225887

Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens.

Georges M G M Verjans1, P Martin van Hagen, Alexander van der Kooi, Albert D M E Osterhaus, G Seerp Baarsma.   

Abstract

The phenotype and antigen-specificity of T cells expanded by mitogenic stimulation from intra-ocular fluid (IOF) samples of affected eyes of six Behçet's disease (BD) patients, and seven patients with other uveitis entities, were determined. High numbers of gammadelta T cells, predominantly Vgamma9Vdelta2 T cells, were only detected in the IOF-derived TCL of three BD patients. Whereas no TCL responded to heat shock protein (HSP) 65 kDa, reactivity to isopentyl pyrophosphate (IPP) and related non-peptide prenyl pyrophosphates (PPP) was restricted to the gammadelta T cell containing TCL. Upon IPP stimulation, these TCL secreted IFN-gamma but no IL-4. By single-cell analysis of intracellular IFN-gamma production and CD69 expression the IOF-derived IPP-specific T cells were identified as CD4(-)CD8(-) gammadelta T cells. The data presented suggest the infiltration of PPP-specific Vgamma9Vdelta2 Th1-like cells into the eye of BD patients with uveitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225887     DOI: 10.1016/s0165-5728(02)00208-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

Review 1.  Behçet's disease: from Hippocrates to the third millennium.

Authors:  D H Verity; G R Wallace; R W Vaughan; M R Stanford
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

2.  Molecular mechanisms in Behçet's disease.

Authors:  R Rajendram; N A Rao
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

3.  Adalimumab: a new modality for Behçet's disease?

Authors:  J A M van Laar; T Missotten; P L A van Daele; A Jamnitski; G S Baarsma; P M van Hagen
Journal:  Ann Rheum Dis       Date:  2006-11-23       Impact factor: 19.103

4.  αβ TCR⁺ T cells, but not B cells, promote autoimmune keratitis in b10 mice lacking γδ T cells.

Authors:  Rebecca L O'Brien; Jennifer L Chain; M Kemal Aydintug; Dawn Bohrer-Kunter; Yafei Huang; Ian R Hardy; John C Cambier; Kevin Lahmers; Tanja Nuhsbaum; Richard Davidson; Deming Sun; Willi K Born
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

5.  The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis.

Authors:  H G Yu; D S Lee; J M Seo; J K Ahn; Y S Yu; W J Lee; H Chung
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

6.  Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report.

Authors:  Sung-Won Lee; Sang-Yeob Lee; Ki-Nam Kim; Jin-Kyu Jung; Won-Tae Chung
Journal:  Clin Rheumatol       Date:  2009-10-09       Impact factor: 2.980

7.  Pro-inflammatory cellular immune response in Behçet's disease.

Authors:  Ayla Kulaber; Ilknur Tugal-Tutkun; Sibel P Yentür; Gülşen Akman-Demir; Fumio Kaneko; Ahmet Gül; Güher Saruhan-Direskeneli
Journal:  Rheumatol Int       Date:  2007-06-05       Impact factor: 2.631

8.  Do synovial biopsies help to support evidence for involvement of innate immunity in the immunopathology of Behçet's disease?

Authors:  Jan A M van Laar; Jasper H Kappen; Paul L A van Daele; P Martin van Hagen
Journal:  Arthritis Res Ther       Date:  2009-04-30       Impact factor: 5.156

9.  Expression of regulatory receptors on γδ T cells and their cytokine production in Behcet's disease.

Authors:  Gunes Parlakgul; Ekin Guney; Burak Erer; Zeki Kılıcaslan; Haner Direskeneli; Ahmet Gul; Guher Saruhan-Direskeneli
Journal:  Arthritis Res Ther       Date:  2013-01-21       Impact factor: 5.156

10.  Distinct synovial immunopathology in Behçet disease and psoriatic arthritis.

Authors:  Juan D Cañete; Raquel Celis; Troy Noordenbos; Conchita Moll; Jose A Gómez-Puerta; Pilar Pizcueta; Antonio Palacin; Paul P Tak; Raimon Sanmartí; Dominique Baeten
Journal:  Arthritis Res Ther       Date:  2009-02-06       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.